Spectral AI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Spectral AI şirketinin toplam hissedar öz sermayesi $-4.3M ve toplam borcu $6.0M olup, bu da borç-öz sermaye oranını -137.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $11.6M ve $15.9M dir.

Anahtar bilgiler

-137.8%

Borç/özkaynak oranı

US$5.97m

Borç

Faiz karşılama oranı	n/a
Nakit	US$3.70m
Eşitlik	-US$4.34m
Toplam yükümlülükler	US$15.94m
Toplam varlıklar	US$11.60m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 43% Price Jump

Nov 03

Slammed 25% Spectral AI, Inc. (NASDAQ:MDAI) Screens Well Here But There Might Be A Catch

Sep 19

Analysts Have Been Trimming Their Spectral AI, Inc. (NASDAQ:MDAI) Price Target After Its Latest Report

Aug 15

Cautious Investors Not Rewarding Spectral AI, Inc.'s (NASDAQ:MDAI) Performance Completely

Jun 28

Many Still Looking Away From Spectral AI, Inc. (NASDAQ:MDAI)

Dec 27

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MDAI negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: MDAI şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MDAI negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: MDAI 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: MDAI son raporlanan serbest nakit akışına göre 4 ay boyunca yeterli nakit pistine sahiptir, ancak o zamandan beri ek sermaye artırmıştır.

Tahmini Nakit Akışı: MDAI tarihsel oranlara göre serbest nakit akışı büyümeye veya küçülmeye devam ederse yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Spectral AI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Spectral AI Announces DeepView SnapShot M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research

Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $2.2701 million.

Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $2.2701 million.

Consensus estimates of losses per share improve by 19%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

New minor risk - Profitability

Spectral AI Announces Management Changes for Spectral IP (to be Renamed SIM IP Inc.)

Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 43% Price Jump

Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers

Spectral AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Spectral AI, Inc. Announces Board Changes

Spectral AI, Inc. Completes Proof of Concept for Wound Measurement Technology

New minor risk - Share price stability

Slammed 25% Spectral AI, Inc. (NASDAQ:MDAI) Screens Well Here But There Might Be A Catch

Spectral AI, Inc. Outlines U.S. Regulatory Pathway for Deepview System for Burn Indication

Spectral AI, Inc. Completes Burn Center Enrollment for U.S. Burn Pivotal Study

New minor risk - Share price stability

Analysts Have Been Trimming Their Spectral AI, Inc. (NASDAQ:MDAI) Price Target After Its Latest Report

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Spectral Ai, Inc. Reiterates Revenue Guidance for Fiscal Year 2024

Spectral AI, Inc. Announces Continuing Progress in Development of Handheld Deepview Snapshot M®? for Military Field Use

Spectral AI, Inc. to Report Q2, 2024 Results on Aug 12, 2024

Spectral AI, Inc. Adds Three New Clinical Trial Sites to Expedite Emergency Department Patient Enrollment

Price target decreased by 8.9% to US$5.65

Spectral AI, Inc. Expands Clinical Trial Sites for Pivotal U.S. Burn Study

Spectral Ai Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study

Cautious Investors Not Rewarding Spectral AI, Inc.'s (NASDAQ:MDAI) Performance Completely

Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Spectral AI, Inc. Reiterates Revenue Guidance for the Year 2024

Spectral AI, Inc. to Report Q1, 2024 Results on May 07, 2024

Spectral AI, Inc. Appoints Erich Spangenberg CEO of Spectral IP, Its Health Care IP-Focused Subsidiary

Spectral AI, Inc., Annual General Meeting, May 14, 2024

Spectral AI, Inc. Announces the Appointment of Jeremiah A. Sparks as Chief Commercialization Officer

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Spectral AI, Inc. announced that it expects to receive $30 million in funding

Spectral AI, Inc. to Report Q4, 2023 Results on Mar 27, 2024

Spectral AI, Inc. Receives UKCA Authorization for Burn Indication Expected Commercialization Second Half 2024

Spectral AI, Inc. Announces Board Changes

Spectral AI, Inc. Announces Resignation of Michael Murphy as Director

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI for Burn Injuries

Spectral AI, Inc. announced that it expects to receive $10 million in funding from B. Riley Principal Capital II, LLC

Spectral AI, Inc. announced that it expects to receive $10 million in funding from B. Riley Principal Capital II, LLC

Many Still Looking Away From Spectral AI, Inc. (NASDAQ:MDAI)

Spectral AI, Inc. Announces Chief Financial Officer Changes

Spectral AI, Inc. Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

Spectral AI, Inc. Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

Third quarter 2023 earnings released: US$0.77 loss per share (vs US$0.008 loss in 3Q 2022)

Spectral AI, Inc. to Report Q3, 2023 Results on Nov 13, 2023

New major risk - Financial position

Spectral AI, Inc. Provides Revenue Guidance for Fiscal Year 2024

Spectral AI, Inc. Provides Revenue Guidance for Fiscal Year 2024

Spectral AI's DeepView SnapShot(R) Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device Classification

Spectral Ai, Inc. Adds Additional Clinical Sites to Multi-Center Diabetic Foot Ulcer Study

Spectral Ai, Inc. Adds Additional Clinical Sites to Multi-Center Diabetic Foot Ulcer Study

Spectral AI, Inc. Appoints Deepak Sadagopan, MHCDS, to Its Board of Directors

High number of new and inexperienced directors

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin